- Q3 2024 Zydus Lifesciences Ltd Earnings Call TranscriptFeb 09, 2024Earnings
- Q2 2024 Zydus Lifesciences Ltd Earnings Call TranscriptNov 07, 2023Earnings
- Q1 2024 Zydus Lifesciences Ltd Earnings Call TranscriptAug 11, 2023Earnings
- Q4 2023 Zydus Lifesciences Ltd Earnings Call TranscriptMay 18, 2023Earnings
- Q3 2023 Zydus Lifesciences Ltd Earnings Call TranscriptFeb 03, 2023Earnings
- Q2 2023 Zydus Lifesciences Ltd Earnings Call TranscriptNov 11, 2022Earnings
- Q1 2023 Zydus Lifesciences Ltd Earnings Call TranscriptAug 10, 2022Earnings
- Q4 2022 Zydus Lifesciences Ltd Earnings Call TranscriptMay 20, 2022Earnings
- Cadila Healthcare Ltd Extraordinary Shareholders Meeting TranscriptFeb 18, 2022
- Q3 2022 Cadila Healthcare Ltd Earnings Call TranscriptFeb 03, 2022Earnings
- Q2 2022 Cadila Healthcare Ltd Earnings Call TranscriptOct 29, 2021Earnings
- Cadila Healthcare Ltd to Discuss About the Emergency Use Authorization of ZyCov-D Vaccine Call TranscriptAug 23, 2021
- Q1 2022 Cadila Healthcare Ltd Earnings Call TranscriptAug 11, 2021Earnings
- Q4 2021 Cadila Healthcare Ltd Earnings Call TranscriptMay 27, 2021Earnings
- Cadila Healthcare Ltd to Discuss the Transaction of Zydus Cadila Entity to Sell Its India Focused Animal Health Business to Multiples Alternate Asset Management Call TranscriptMay 12, 2021
- Q3 2021 Cadila Healthcare Ltd Earnings Call TranscriptFeb 05, 2021Earnings
- Q2 2021 Cadila Healthcare Ltd Earnings Call TranscriptNov 02, 2020Earnings
- Q1 2021 Cadila Healthcare Ltd Earnings Call TranscriptAug 05, 2020Earnings
- Q4 2020 Cadila Healthcare Ltd Earnings Call TranscriptJun 19, 2020Earnings
- Q3 2020 Cadila Healthcare Ltd Earnings Call TranscriptFeb 05, 2020Earnings
- Q2 2020 Cadila Healthcare Ltd Earnings Call TranscriptNov 13, 2019Earnings
- Q1 2020 Cadila Healthcare Ltd Earnings Call TranscriptAug 09, 2019Earnings
- Q4 2019 Cadila Healthcare Ltd Earnings Call TranscriptMay 29, 2019Earnings
Q1 2024 Zydus Lifesciences Ltd Earnings Call Transcript
Welcome to Zydus Lifesciences Limited Q1 FY '24 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Ganesh Nayak, Executive Director of Zydus Lifesciences. Thank you, and over to you, sir.
Good afternoon, ladies and gentlemen. Welcome to our post results teleconference for the quarter ended 30th June 2023. On this call, we have with us Dr. Sharvil Patel, Managing Director; Mr. Nitin Parekh, Chief Financial Officer; Mr. Arvind Bothra, Senior Vice President, Investor Relations; and Mr. Alok Garg, Senior Vice President from the Managing Director's Office.
Let me now give you a broad overview of the developments during the quarter. We had a strong start to the financial year as we capitalized on the momentum built over the last several quarters and delivered robust growth across businesses. This, coupled with sustained improvement in profitability, helped us achieve the highest
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)